Author | Mitchell R. Smith, MD, PhD | OncLive

Author | Mitchell R. Smith, MD, PhD

Articles

Dr. Smith on the Rationale Behind the Fixed Duration Trial for Ibrutinib/Venetoclax in CLL

December 10, 2019

Video

Mitchell R. Smith, MD, PhD, discusses the rationale behind the trial looking at the fixed duration of the ibrutinib and venetoclax combination in chronic lymphocytic leukemia.

Dr. Smith on PI3K Inhibitors in CLL

November 02, 2019

Video

Mitchell R. Smith, MD, PhD, division director, Cancer and Blood Disorders, and professor of medicine, GW Cancer Center, discusses the use of PI3K inhibitors in chronic lymphocytic leukemia (CLL).

Dr. Smith on Frontline Treatment Considerations in CLL

October 24, 2019

Video

Mitchell R. Smith, MD, PhD, discusses frontline treatment considerations in patients with chronic lymphocytic leukemia.

Dr. Smith on Using Venetoclax Versus Ibrutinib in CLL

October 17, 2019

Video

Mitchell R. Smith, MD, PhD, discusses the use of venetoclax versus ibrutinib in patients with chronic lymphocytic leukemia.

x